Share on Facebook Share on Twitter Email
Answers.com

serotonin

Did you mean: serotonin (in biology, chemistry), 5-hydroxytryptamine, Raven's Nest, Serotonin (Lyrics - Nine Horses), Serotonin (Lyrics - Mansun), Serotonin (Lyrics - Simple Kid)

 
Dictionary: se·ro·to·nin   (sĕr'ə-tō'nĭn, sîr'-) pronunciation
n.
An organic compound, C10H12N2O, formed from tryptophan and found in animal and human tissue, especially the brain, blood serum, and gastric mucous membranes, and active as a neurotransmitter and in vasoconstriction, stimulation of the smooth muscles, and regulation of cyclic body processes.

[SERO- + TON(E) + -IN.]


Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Sci-Tech Encyclopedia: Serotonin
Top

A compound, also known as 5-hydroxytryptamine (5-HT), derived from tryptophan, an indole-containing amino acid. It is widely distributed in the animal and vegetable kingdoms. In mammals it is found in gastrointestinal enterochromaffin cells, in blood platelets, and in brain and nerve tissue. Serotonin is a local vasoconstrictor, plays a role in brain and nerve function and in regulation of gastric secretion and intestinal peristalsis, and has pharmacologic properties. It is inactivated by monoamine oxidases (MAO-A and -B), enzymes that also inactivate other neurotransmitters such as norepinephrine and dopamine.

Serotonin is concentrated in certain areas of the brain; the hypothalamus and midbrain contain large amounts, while the cortex and cerebellum contain low concentrations. Like most neurotransmitters, it is stored in granules inside nerve endings, and is thus not exposed to inactivation by monoamine oxidases until it is released into the synaptic space between nerves. When a serotonin-containing nerve fires, serotonin is released and can bind to any one of a series of at least 14 distinct downstream serotonin receptors (5-HT receptors). Release of serotonin or other stored neurotransmitters can also be induced by alkaloids such as reserpine, which have been used as tranquilizing agents in the treatment of nervous and mental disorders. Although pharmacologic doses of serotonin produce a type of sedation and other depressant conditions of the nervous system, several types of clinically useful antidepressants, such as monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, and selective serotonin reuptake inhibitors (SSRIs), act by increasing the amount of active serotonin in nerve synapses in particular brain regions. Conversely, various conditions that lower serotonin levels are associated with depression, suggesting that normal to slightly elevated serotonin levels tend to elevate mood and prevent depression. See also Affective disorders; Brain; Nervous system (vertebrate); Neurosecretion; Psychopharmacology.


World of the Body: serotonin
Top

After blood is allowed to clot a substance can be extracted from the fluid serum which, when injected, causes an increase in blood vessel ‘tone’ (the vessels' state of contraction). This serum-derived substance was therefore called serotonin or vasotonin. Similarly, extraction of animal intestines yielded a material with similar actions termed enteramine — the name being derived from the term enteron (gut). Serotonin, vasotonin, and enteramine were found to be identical. Chemically the vasoactive agent was 5-hydroxytryptamine (5HT). This is an endogenous autacoid (a substance made by body cells, which has some action on other cells) and is derived from the amino acid tryptophan, obtained from protein in the diet.

It is now known that 5HT is widely distributed throughout the body, with a multitude of actions. Ninety per cent of the total body content of 5HT is found in the enterochromaffin cells in the wall of the intestine. Most of the rest is found in blood platelets, and released from these when blood clots. A small amount is also found in the brain, especially the mid-brain, where it acts as a neurotransmitter.

5HT can act on a cell only if the cell membrane has specific 5HT receptors, and there are sub-types of these receptors on different cells, associated with different actions of 5HT upon them. 5HT causes many smooth muscles (involuntary muscles) to contract, such that gut motility and peristalsis are increased and contraction of the smooth muscle of blood vessels causes the blood pressure to rise. The smallest arterioles, however, are dilated, resulting in increased capillary pressure and capillary permeability, causing an increase in the rate of formation of tissue fluid. But 5HT also reduces the release of noradrenaline from sympathetic nerves, by acting on 5HT1 receptors on the nerve terminals, which tends to reduce blood pressure. The vasoconstrictor response on the larger blood vessels is mediated by 5HT2 receptors. Consequently, in the presence of a 5HT2 antagonist, when 5HT can act only on the 5HT1 receptors, it causes a fall rather than a rise in blood pressure.

5HT exerts many of its actions indirectly by either stimulating or inhibiting the release of other neurotransmitters. An example of inhibition of neurotransmitter release is given above, whereas in the gut it is stimulation of acetylcholine release from neurons of the myenteric plexus in the gut wall that increases contractions and secretions. 5HT can also stimulate sensory nerve endings directly, causing a pain sensation — well known to those who have suffered nettle stings, which contain 5HT.

Although only 1% of the body's total 5HT occurs in the brain it is here that the actions of this substance are the most profound. The neurons containing 5HT are concentrated in the raphe nuclei in the mid-brain and their fibres project in a diffuse way to the cerebral cortex, hippocampus, limbic system, and hypothalamus as well as down the spinal cord — a distribution not dissimilar to that of noradrenergic fibres.

Modern molecular biological studies have shown that there are many different types of receptors for 5HT — perhaps as many as ten — whose precise functional responsibilities are not yet clear. There is clear evidence that 5HT is involved in sleep, wakefulness, and mood. Descending 5HT pathways (from the brain down the spinal cord) affect the excitability of spinal motorneurons, activating those involved in simple reflexes and inhibiting more complex reflexes. Animals deprived of 5HT (by giving agents that prevent its synthesis) show exaggerated responses to many types of sensory stimulus, indicating that 5HT normally exerts a modifying effect, allowing irrelevant stimuli to be ignored and the response to pain palliated. 5HT is also involved at the level of the hypothalamus in temperature regulation and in the control of factors which release hormones from the anterior pituitary gland; also in the central control of vomiting.

There is much evidence to suggest that major changes in the blood vessels on the surface of the brain, which underlie migraine, are caused by release of 5HT. After an initial vasoconstrictor phase has passed the brain vessels dilate, and it is thought this is responsible for the pain. Drugs used to treat this condition, such as Sumatriptan, are antagonists at the receptor sub-type 5HT1d.

Lysergic acid diethylamide (LSD) is one of the most notorious mood-altering (psychomimetic/hallucinogenic) drugs, producing bizarre visual experiences together with marked motor unrest and vocalization of extraordinary utterances. Mental function is altered so that perception of all sensory input — visual, auditory, tactile or olfactory — is distorted. In the brain LSD is able to activate 5HT receptors although elsewhere LSD is an antagonist. The psychomimetic effects of LSD certainly involve interference with the multiple actions of 5HT in the brain. Users of LSD describe both good and bad ‘trips’, which may mean that the response to LSD is dependent on the state of the 5HT system when the drug is taken. With 5HT, as with many neurotransmitters, the body economizes by using reuptake mechanisms: after a neurotransmitter has been released and has acted on post synaptic receptors the transmitter in the vicinity of the nerve terminal is taken up, stored, and recycled when the next nerve impulse arrives. In recent years drugs have been developed which specifically block the reuptake of 5HT. Clearly this is useful if reduction in the effectiveness of 5HT transmission in the brain has led to depression. Selective serotonin reuptake inhibitors (SSRIs) have proved useful mood-improving drugs; the best known is fluoxetine (Prozac), although there have been adverse criticisms of its use as many patients are reluctant to give it up, even when the condition precipitating the depression has passed.

— Alan W. Cuthbert

See also neurotransmitters; membrane receptors.

Food and Fitness: serotonin
Top

entramine; 5-hydroxytryptamine

Serotonin is a chemical derived from the amino acid tryptophan. It plays a key part in a number of reactions in the brain and other tissues. In the blood, it acts as a vasoconstrictor, narrowing blood vessels, and is involved in the inflammation response. In the brain, serotonin is a neurotransmitter, affecting the activity of nerve cells. Brain concentrations are affected by diet in quite a complex way depending on the ability of tryptophan to cross the barrier between blood and the brain. Generally, carbohydrate-rich diets increase tryptophan levels, accelerating serotonin production. Some protein-rich diets (those containing the amino acids tyrosine, phenylalanine, leucine, isoleucine, and valine) compete with tryptophan to get across the blood-brain barrier, depress tryptophan uptake into the brain, and reduce serotonin levels.

Changes in serotonin levels can alter mood: increases have a calming effect, relieving depression, insomnia, and irritability; decreases are associated with wakefulness and greater sensitivity to pain. There is also a link between high serotonin levels and the early onset of fatigue: elevated levels induce lethargy and reduce the desire to exercise. Attempts have been made by some sports scientists to see if reducing serotonin levels can improve physical performance, but the results so far are inconclusive. See also branched chain amino acids.

 
Columbia Encyclopedia: serotonin
Top
serotonin (sĕr'ətō'nĭn), organic compound that was first recognized as a powerful vasoconstrictor occurring in blood serum. It was partially purified, crystallized, and named in 1948, and its structure was deduced a year later. Independent work indicated that serotonin was widely distributed in nature and occurred in tissues other than blood. It has been shown to be in many representatives of the animal kingdom, in wasp stings and scorpion venom, in various fruits, such as pineapples, bananas, and plums, and in various nuts. It has been estimated that an adult human contains about 5 to 10 mg of serotonin, 90% of which is in the intestine and the rest in blood platelets and the brain. One role of the compound is as a neurotransmitter whose participation is being sought in diverse functions including learning, sleep, and control of mood. The structural similarity of serotonin to several drugs known to cause mental aberrations, such as LSD, has prompted much speculation as to the role of serotonin in naturally occurring mental disorders such as schizophrenia or depression. The function of serotonin in blood platelets is not clear; it seems to have no important role in the clotting mechanism. Its function in stings and venoms might be that of an irritant, since intravenous injections of serotonin in humans produce pain at the site of injection, gasping, coughing, a general tingling and prickling sensation, nausea, cramps, and other unpleasant symptoms.


Wikipedia: Serotonin
Top
Serotonin
Serotonin (5-HT).svg
Serotonin-3D-vdW.png
IUPAC name
Other names 5-hydroxytryptamine, 5-HT, N-methyl-gamma
Identifiers
CAS number 50-67-9 Yes check.svgY
PubChem 5202
MeSH Serotonin
SMILES
InChI
ChemSpider ID 5013
Properties
Molecular formula C10H12N2O
Molar mass 176.215
Appearance White powder
Melting point

167.7 °C, 441 K, 334 °F

 Yes check.svgY (what is this?)  (verify)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Serotonin (pronounced /ˌsɛrəˈtoʊnən/) is a monoamine neurotransmitter. It is found extensively in the gastrointestinal tract of animals, and about 80 to 90 percent of the human body's total serotonin is located in the enterochromaffin cells in the gut, where it is used to regulate intestinal movements.[1][2] The remainder is synthesized in serotonergic neurons in the central nervous system (CNS) where it has various functions, including the regulation of mood, appetite, sleep, muscle contraction, and some cognitive functions including memory and learning; and in blood platelets where it helps to regulate hemostasis and blood clotting.

Serotonin is found not only in animals, but also in fungi and plants,[3] including fruits and vegetables.

Contents

Function

Serotonin functions as a neurotransmitter in nerve systems of simple as well as complex animals. For example, in the roundworm Caenorhabditis elegans, which feeds by grazing on bacteria, serotonin acts like a signal of positive life events i.e. finding a new grazing ground. When a well-fed worm feels bacteria on its cuticle, dopamine is released, which slows it down; if it is starved, serotonin also is released, which slows the animal down further. This mechanism increases the amount of time animals spend in the presence of food. [4]

The released serotonin activates the muscles used for feeding, while octopamine suppresses them.[5] Serotonin diffuses to serotonin-sensitive neurons, which control the animal's perception of nutrient availability. Artificial depletion of serotonin or increase of octopamine cues behavior that is typical of a low-food environment: C. elegans becomes more active, and mating and egg-laying is suppressed, while the opposite occurs if serotonin is increased or octopamine is decreased in this animal.[6]

Serotonin is nessesary for normal male mating behavior [7], and the inclination to leave food to search for a mate.[8] The serotonergic signaling used to adapt the worms behaviour to fast changes in the environment affects insulin-like signaling and the TGF beta signaling pathway, which control long-term adaption. Mutants lacking serotonin have a increased reproductive lifespan, they become obese and some of the animals arrest their development at a inactive larval state. [9] [10]. In the fruitfly where insulin both regulates blood sugar and acts as a growth factor serotonergic neurons regulate the adult body size by affecting insulin secretion. [11] [12] Altrough these two functions have separated in humans so that insulin regulates blood sugar and IGF regulates growth, serotonin still controlls the release of both hormones so that serotonin suppresses insulin release from the beta cells in the pancreas[13], and exposure to SSRIs reduces fetal growth. [14]

Serotonin can also act as a growth factor directly. Liver damage increases cellular expression of 5-HT2A and 5-HT2B receptors.[15] Serotonin present in the blood then stimulates cellular growth to repair liver damage.[16] 5HT2B receptors also activate osteoblasts, which build up bone.[17] However, serotonin also activates osteoclasts, which degrade bone.[18][19] Serotonin in addition evokes endothelial nitric oxide synthase activation and stimulates through a 5-HT1B receptor meditated mechanism the phosphorylation of p44/p42 mitogen-activated protein kinase activation in bovine aortic endothelial cell cultures.[20]

How much food an animal gets is not only dependent on the abundance of food in the environment but also on the animals social rank, since the stronger animals may steal food from the weaker. This may explain why serotonin is not only involved in the perception of food availability but also of social rank. If a lobster is injected with serotonin, it behaves like a dominant animal, while octopamine causes subordinate behavior.[21]

A frightened crayfish flips its tail to flee, and the effect of serotonin on this behavior depends on the animal's social status. Serotonin inhibits the fleeing reaction in subordinates, but enhances it in socially dominant or isolated individuals. Social experience alters the proportion between different serotonin receptors that have opposing effects on the fight-or-flight response. The effect of 5-HT1 receptors predominates in subordinate animals while 5-HT2 receptors predominates in dominants.[22] The same might be true in humans since levels of 5-HT1A receptor activation in the brain show negative correlation with aggression,[23] and a mutation in the gene that codes for the 5-HT2A receptor may double the risk of suicide for those with that genotype.[24]

Serotonergic signaling plays an important role in the modulation of human mood, anger and aggression. Individuals of C.elegans facing stress (eg. a low-food environment) resume normal behavior if given serotonin-increasing drugs. The same drugs have similar effects in humans; the action of serotonin on the worms' mating and egg-laying resembles its effects on human sexuality.[citation needed]

Serotonin has broad activities in the brain, and genetic variation in serotonin receptors and the serotonin transporter, which facilitates re-uptake of serotonin into presynapses, have been implicated in neurological diseases. Drugs targeting serotonin-induced pathways are being used in the treatment of many psychiatric disorders. One focus of clinical research is the influence of genetics on serotonin action and metabolism in psychiatric settings. Such studies have revealed that the variation in the promoter region of the serotonin transporter protein accounts for nearly 10% of total variance in anxiety-related personality,[25] and the effect of this gene on depression was found to interact with the environment.[26]

In the ultimatum game, participants whose serotonin levels have been artificially lowered will reject unfair offers more often than players with normal serotonin levels.[27]

Serotonin also has effects on appetite, sleep and general metabolism. In the blood, the major storage site is platelets, which collect serotonin from plasma. Bleeding causes serotonin release, which constricts blood vessels.[28] Irritants present in food trigger the enterochromaffin cells to release serotonin to increase peristaltic movements for emptying of the gut. Leakage of intestinal serotonin into the bloodstream at a rate faster than the platelets can absorb it increases free serotonin in the blood, which activates 5HT3 receptors in the chemoreceptor trigger zone that stimulate vomiting.[29]


Serotonin in the central nervous system is not essential to viability in some mammals, as shown for mice that are genetically altered so that they are unable to produce serotonin in the brain stem. These mice can live into adulthood and even give birth to live pups.[30] Although brain serotonin is not essential for viability, its ablation causes impairment such as growth retardation, 50% mortality in the first four weeks of postnatal life, and effects on various physiological and behavioral pathways that originate from the autonomic nervous system. Specifically, mice dams that lack serotonin in the brain are less able to rear pups and show more aggression towards other mice.[30]

Anatomy

Serotonin system, contrasted with dopamine system.

Gross anatomy

The neurons of the raphe nuclei are the principal source of 5-HT release in the brain.[31] The raphe nuclei are neurons grouped into about nine pairs and distributed along the entire length of the brainstem, centered around the reticular formation.[32]

Axons from the neurons of the raphe nuclei form a neurotransmitter system, reaching large areas of the brain. Axons of neurons in the caudal raphe nuclei terminate in the following locations:

On the other hand, axons of neurons in the rostral raphe nuclei terminate in e.g.:

Thus, activation of this serotonin system has effects on large areas of the brain.

Microanatomy

Serotonin is released from serotonergic varicosities (swellings) into the extra neuronal space, but not from synaptic terminal boutons as other neurotransmitters.[citation needed] Serotonin diffuses over a relatively wide gap (>20 µm) to activate 5-HT receptors located on the dendrites, cell bodies and presynaptic terminals of adjacent neurons.

Receptors

5-HT receptors are the receptors for serotonin. They are located on the cell membrane of nerve cells and other cell types in animals and mediate the effects of serotonin as the endogenous ligand and of a broad range of pharmaceutical and hallucinogenic drugs. With the exception of the 5-HT3 receptor, a ligand gated ion channel, all other 5-HT receptors are G protein coupled seven transmembrane (or heptahelical) receptors that activate an intracellular second messenger cascade [33].

Termination

Serotonergic action is terminated primarily via uptake of 5-HT from the synapse. This is through the specific monoamine transporter for 5-HT, SERT, on the presynaptic neuron. Various agents can inhibit 5-HT reuptake including MDMA (ecstasy), amphetamine, cocaine, dextromethorphan (an antitussive), tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).

Interestingly, a 2006 study conducted by the University of Washington suggested that a newly discovered monoamine transporter, known as PMAT, may account for "a significant percentage of 5-HT clearance".[34] Contrasting with the high-affinity SERT, the PMAT has been identified as a low affinity transporter with an apparent Km of 114 micromoles/L for serotonin; approximately 230 times higher than that of SERT. However, the PMAT, despite its relatively low serotonergic affinity, has a considerably higher transport capacity than SERT, "..resulting in roughly comparable uptake efficiencies to SERT in heterologous expression systems." The study also suggests that some SSRIs, such as fluoxetine and sertraline, inhibit PMAT but at IC50 values which surpass the therapeutic plasma concentrations by up to four orders of magnitudes; therefore, SSRI monotherapy is ineffective in PMAT inhibition. At present, there are no known pharmaceuticals which would appreciably inhibit PMAT at normal therapeutic doses. The PMAT also suggestively transports dopamine and norepinephrine albeit at Km values even higher than that of 5-HT (330–15,000 micromoles/L).

Serotonylation

Serotonin can also signal through a nonreceptor mechanism called serotonylation. In this serotonin modifies proteins.[13] This process underlies serotonin effects upon platelet-forming cells (thrombocyte)s in which it links to the modification of signaling enzymes called GTPases that then trigger the release of vesicle contents by exocytosis.[35] A similar process underlies the pancreatic release of insulin.[13] The effects of serotonin upon vascular smooth muscle "tone" (this is the biological function from which serotonin originally got its name) depend upon the serotonylation of proteins involved in the contractile apparatus of muscle cells.[36]

Biosynthesis

The pathway for the synthesis of serotonin from tryptophan.

In animals including humans, serotonin is synthesized from the amino acid L-tryptophan by a short metabolic pathway consisting of two enzymes: tryptophan hydroxylase (TPH) and amino acid decarboxylase (DDC). The TPH-mediated reaction is the rate-limiting step in the pathway. TPH has been shown to exist in two forms: TPH1, found in several tissues, and TPH2, which is a brain-specific isoform.[37] The 5-HTT gene (5-hydroxytryptamine transporter, or SLC6A4 = solute carrier family 6 (neurotransmitter transporter, serotonin), member 4) regulates serotonin. This chemical is found in very low amounts in people diagnosed with depression compared to other people. Serotonin works as a neurotransmitter and helps with the modulation of things such as anger, appetite, sexuality, sleep, mood, and several other things. People with depression often have impaired 5-HTT genes. There are two forms of the 5-HTT gene and everyone has two 5-HTT genes. (Levinson) There is a long form of 5-HTT and a short form of 5-HTT. Research shows that people with both 5-HTT genes being the long form are less likely to become depressed while people with one short and one long or two short forms are more likely to develop depression. Research is still being conducted to find more information.[38] There is also evidence that ovarian hormones can affect the expression of TPH in various species, suggesting a possible mechanism for postpartum depression and premenstrual stress syndrome.[citation needed] Serotonin biosynthesis in plants likewise begins with L-tryptophan, which is however first decarboxylated by tryptophan decarboxylase to give tryptamine, which is then hydroxylated by the cytochrome P450 monooxygenase, tryptamine 5-hydroxylase, yielding serotonin.[39]

Serotonin taken orally does not pass into the serotonergic pathways of the central nervous system because it does not cross the blood-brain barrier. However, tryptophan and its metabolite 5-hydroxytryptophan (5-HTP), from which serotonin is synthesized, can and do cross the blood-brain barrier. These agents are available as dietary supplements and may be effective serotonergic agents.

One product of serotonin breakdown is 5-Hydroxyindoleacetic acid (5 HIAA), which is excreted in the urine. Serotonin and 5 HIAA are sometimes produced in excess amounts by certain tumors or cancers, and levels of these substances may be measured in the urine to test for these tumors.

Drugs targeting the 5-HT system

Several classes of drugs target the 5-HT system including some antidepressants, antipsychotics, anxiolytics, antiemetics, and antimigraine drugs as well as the psychedelic drugs and empathogens.

Psychedelic drugs

The psychedelic drugs psilocin/psilocybin, DMT, mescaline, and LSD are agonists primarily at 5-HT2A/2C receptors.[40][41] The empathogen MDMA (ecstasy) releases serotonin from synaptic vesicles of neurons.[42]

Antidepressants

The MAOIs prevent the breakdown of monoamine neurotransmitters (including serotonin), and therefore increase concentrations of the neurotransmitter in the brain. MAOI therapy is associated with many adverse drug reactions, and patients are at risk of hypertensive emergency triggered by foods with high tyramine content and certain drugs.

Some drugs inhibit the re-uptake of serotonin, making it stay in the synapse longer. The tricyclic antidepressants (TCAs) inhibit the re-uptake of both serotonin and norepinephrine. The newer selective serotonin re-uptake inhibitors (SSRIs) have fewer side-effects and fewer interactions with other drugs. The side effects that have become apparent in recent times include a decrease in bone mass in elderly and increased risk for osteoporosis. However, it is not yet clear whether it is due to SSRI action on peripheral serotonin production and or action in the gut or in the brain.[43]

Certain SSRI medications have been shown to lower serotonin levels below the baseline after chronic use, despite initial increases in serotonin. This has been connected to the observation that the benefit of SSRI's may decrease in selected patients after a long-term treatment. A switch in medication will usually resolve this issue (up to 70% of the time).[44]

The novel antidepressant tianeptine, a selective serotonin reuptake enhancer, has mood-elevating effects. This provides evidence for the theory that serotonin is most likely used to regulate the extent or intensity of moods.

Antiemetics

5-HT3 antagonists such as ondansetron, granisetron, and tropisetron are important antiemetic agents. They are particularly important in treating the nausea and vomiting that occur during anticancer chemotherapy using cytotoxic drugs. Another application is in the treatment of post-operative nausea and vomiting. Applications to the treatment of depression and other mental and psychological conditions have also been investigated with some positive results.[citation needed]

Pathology

Defective signalling of serotonin in the brain may be the root cause of sudden infant death syndrome (SIDS). Scientists from the European Molecular Biology Laboratory in Monterotondo, Italy,[45] genetically modified lab mice to produce low levels of the neurotransmitter serotonin. The results showed the mice suffered drops in heart rate and other symptoms of SIDS, and many of the animals died at an early age.

Researchers now believe that low levels of serotonin in the animals' brainstems, which control heartbeat and breathing, may have caused sudden death, researchers said in the July 4, 2008 issue of Science.[46]

If neurons that make serotonin — serotonergic neurons — are abnormal in infants, there is a risk of sudden infant death syndrome (SIDS).[47][48] Low levels of serotonin may also be associated with intense spiritual experiences.[49]

Recent research conducted at Rockefeller University shows that both in patients who suffer from depression and in mice that model the disorder, levels of the p11 protein are decreased. This protein is related to serotonin transmission within the brain.[50]

Obsessive-compulsive disorder (OCD) can be a debilitating disorder with the following two anxiety-related essential features: obsessions (undesirable, recurrent, disturbing thoughts) and compulsions (repetitive or ritualized behaviors). SSRIs, and other medicines which alter serotonin levels, have been approved to be used to treat symptoms of OCD.

Serotonin syndrome

Extremely high levels of serotonin can have toxic and potentially fatal effects, causing a condition known as serotonin syndrome. In practice, such toxic levels are essentially impossible to reach through an overdose of a single anti-depressant drug, but require a combination of serotonergic agents, such as an SSRI with an MAOI.[51] The intensity of the symptoms of serotonin syndrome vary over a wide spectrum, and the milder forms are seen even at non-toxic levels.[52][citation needed]

Chronic diseases resulting from serotonin 5-HT2B overstimulation

In blood, serotonin stored in platelets is active wherever platelets bind, as a vasoconstrictor to stop bleeding, and also as a fibrocyte mitotic, to aid healing. Because of these effects, overdoses of serotonin, or serotonin agonist drugs, may cause acute or chronic pulmonary hypertension from pulmonary vasoconstriction, or else syndromes of retroperitoneal fibrosis or cardiac valve fibrosis (endocardial fibrosis) from overstimulation of serotonic growth receptors on fibrocytes.[citation needed]

Serotonin itself may cause a syndrome of cardiac fibrosis when it is eaten in large quantities in the diet (the Matoki banana of East Africa) or when it is over-secreted by certain mid-gut carcinoid tumors.[citation needed] The valvular fibrosis in such cases is typically on the right side of the heart, since excess serotonin in the serum outside platelets is metabolized in the lungs, and does not reach the left circulation.[citation needed]

Serotonergic agonist drugs in overdose in experimental animals not only cause acute (and sometimes fatal) pulmonary hypertension, but there is epidemiologic evidence that chronic use of certain of these drugs produce a chronic pulmonary hypertensive syndrome in humans.[citation needed] Some serotonergic agonist drugs also cause fibrosis anywhere in the body, particularly the syndrome of retroperitoneal fibrosis, as well as cardiac valve fibrosis.[53]

In the past, three groups of serotonergic drugs have been epidemiologically linked with these syndromes. They are the serotonergic vasoconstrictive anti-migraine drugs (ergotamine and methysergide),[53] the serotonergic appetite suppressant drugs (fenfluramine, chlorphentermine, and aminorex), and certain anti-parkinsonian dopaminergic agonists, which also stimulate serotonergic 5-HT2B receptors. These include pergolide and cabergoline, but not the more dopamine-specific lisuride.[54] As with fenfluramine, some of these drugs have been withdrawn from the market after groups taking them showed a statistical increase of one or more of the side effects described. An example is pergolide. The drug was in decreasing use since reported in 2003 to be associated with cardiac fibrosis.[55] Two independent studies published in the New England Journal of Medicine in January 2007, implicated pergolide along with cabergoline in causing valvular heart disease.[56][57] As a result of this, the FDA removed pergolide from the U.S. market in March, 2007.[58] (Since cabergoline is not approved in the U.S. for Parkinson's Disease, but for hyperprolactinemia, the drug remains on the market. Treatment for hyperprolactinemia requires lower doses than that for Parkinson's Disease, diminishing the risk of valvular heart disease).[59]

Because neither the amino acid L-tryptophan nor the SSRI-class antidepressants raise blood serotonin levels[citation needed], they are not under suspicion to cause the syndromes described. However, since 5-hydroxytryptophan (5-HTP) does raise blood serotonin levels, it is under some of the same scrutiny as actively serotonergic drugs.[citation needed]

In unicellular organisms

Serotonin is used by a variety of single-cell organisms for various purposes. Selective serotonin re-uptake inhibitors (SSRIs) have been found to be toxic to algae.[60] The gastrointestinal parasite Entamoeba histolytica secretes serotonin, causing a sustained secretory diarrhea in some patients.[61][62] Patients infected with Entamoeba histolytica have been found to have highly elevated serum serotonin levels which returned to normal following resolution of the infection.[63] Entamoeba histolytica also responds to the presence of serotonin by becoming more virulent.[64]

In plants

Serotonin is found in mushrooms and plants, including fruits and vegetables. The highest values of 25–400 mg/kg have been found in nuts of the walnut (Juglans) and hickory (Carya) genuses. Serotonin concentrations of 3–30 mg/kg have been found in plantain, pineapple, banana, kiwifruit, plums, and tomatoes. Moderate levels from 0.1–3 mg/kg have been found in a wide range of tested vegetables.[65] Serotonin is one compound of the poison contained in stinging nettles (Urtica dioica). It should be noted that serotonin, unlike its precursors 5-HTP and tryptophan, does not cross the blood–brain barrier, which means that ingesting serotonin in the diet has no effect on brain serotonin levels. Several plants contain serotonin together with a family of related tryptamines that are methylated at the amino (NH2) and hydroxy (OH) groups, are N-oxides, or miss the OH group. Examples are plants from the Anadenanthera genus that are used in the hallucinogenic yopo snuff.

In animals

Serotonin as a neurotransmitter is found in many animals, including insects. Several toad venoms, as well as that of the Brazilian wandering spider and stingray, contain serotonin and related tryptamines. It has also been identified as the trigger for swarm behavior in locusts.[66]

History

Serotonin was originally discovered by Italian Vittorio Erspamer in Rome in 1935 and American scientists in the late 1940s. Isolated and named in 1948 by Maurice M. Rapport, Arda Green, and Irvine Page of the Cleveland Clinic,[67] the name serotonin is something of a misnomer and reflects the circumstances of the compound's discovery. It was initially identified as a vasoconstrictor substance in blood serum – hence serotonin, a serum agent affecting vascular tone. This agent was later chemically identified as 5-hydroxytryptamine (5-HT) by Rapport, and, as the broad range of physiological roles were elucidated, 5-HT became the preferred name in the pharmacological field.

Increasing serotonin levels

There are many ways serotonin levels can be increased, many due to diet. An increase in the ratio of tryptophan to phenylalanine and leucine will increase serotonin levels. Fruits with a good ratio include dates, papaya and banana. Foods with a lower ratio inhibit the production of serotonin. These include whole wheat and rye bread.[68] Research indicates that vigorous aerobic exercise improves mood through BDNF expression, there is however no direct evidence that this is caused by an increase in serotonin levels.[69] Research also suggests that eating a diet rich in whole grain carbohydrates and low in protein will increase serotonin by secreting insulin, which helps in amino acid competition.[70] However, increasing insulin for a long period of time can sometimes onset insulin resistance, which is related to obesity, type 2 diabetes, and lower serotonin levels. It is also believed that muscles use many of the amino acids except tryptophan, allowing men to have more serotonin than women.[71] Bright light therapy may have an effect on blood serotonin levels.[72] A similar effect is obtained by spending more time in natural sunlight.[73] Recently, acupuncture has been shown to stimulate the release of serotonin in lab animals.[74]

Myo-inositol, a carbocyclic polyol present in many foods, is known to play a role in serotonin modulation.[75]

References

  1. ^ Indiana State University
  2. ^ Berger M, Gray JA, Roth BL (2009). "The expanded biology of serotonin". Annual Review of Medicine 60: 355–66. doi:10.1146/annurev.med.60.042307.110802. PMID 19630576. 
  3. ^ Kang K, Park S, Kim YS, Lee S, Back K (2009). "Biosynthesis and biotechnological production of serotonin derivatives". Appl Microbiol Biotechnol 83 (1): 27–34. doi:10.1007/s00253-009-1956-1. PMID 19308403. 
  4. ^ Sawin ER, Ranganathan R, Horvitz HR (June 2000). "C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway". Neuron 26 (3): 619–31. PMID 10896158. http://www.cell.com/neuron/fulltext/S0896-6273(00)81199-X. 
  5. ^ Timothy Niacaris,Leon Avery: "Serotonin regulates repolarization of the C. elegans pharyngeal muscle", The Journal of Experimental Biology 206, 223-231 (2003) http://jeb.biologists.org/cgi/content/full/206/2/223
  6. ^ Supriya Srinivasan, Leila Sadegh, Ida C. Elle, Anne G.L. Christensen,Nils J. Faergeman, Kaveh Ashrafi: "Serotonin Regulates C. elegans Fat and Feeding through Independent Molecular Mechanisms", Cell Metabolism, Volume 7, Issue 6, 533-544, 4 June 2008 http://www.cell.com/cell-metabolism/abstract/S1550-4131(08)00144-7
  7. ^ Loer CM, Kenyon CJ (December 1993). "Serotonin-deficient mutants and male mating behavior in the nematode Caenorhabditis elegans". J. Neurosci. 13 (12): 5407–17. PMID 8254383. http://www.jneurosci.org/cgi/pmidlookup?view=long&pmid=8254383. 
  8. ^ Lipton J, Kleemann G, Ghosh R, Lints R, Emmons SW (August 2004). "Mate searching in Caenorhabditis elegans: a genetic model for sex drive in a simple invertebrate". J. Neurosci. 24 (34): 7427–34. doi:10.1523/JNEUROSCI.1746-04.2004. PMID 15329389. http://www.jneurosci.org/cgi/pmidlookup?view=long&pmid=15329389. 
  9. ^ Ben Arous J, Laffont S, Chatenay D (2009). "Molecular and sensory basis of a food related two-state behavior in C. elegans". PLoS ONE 4 (10): e7584. doi:10.1371/journal.pone.0007584. PMID 19851507. PMC 2762077. http://dx.plos.org/10.1371/journal.pone.0007584. 
  10. ^ Sze JY, Victor M, Loer C, Shi Y, Ruvkun G (February 2000). "Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant". Nature 403 (6769): 560–4. doi:10.1038/35000609. PMID 10676966. http://dx.doi.org/10.1038/35000609. 
  11. ^ Kaplan DD, Zimmermann G, Suyama K, Meyer T, Scott MP (July 2008). "A nucleostemin family GTPase, NS3, acts in serotonergic neurons to regulate insulin signaling and control body size". Genes Dev. 22 (14): 1877–93. doi:10.1101/gad.1670508. PMID 18628395. PMC 2492735. http://genesdev.cshlp.org/cgi/pmidlookup?view=long&pmid=18628395. 
  12. ^ Ruaud AF, Thummel CS (July 2008). "Serotonin and insulin signaling team up to control growth in Drosophila". Genes Dev. 22 (14): 1851–5. doi:10.1101/gad.1700708. PMID 18628391. PMC 2735276. http://www.genesdev.org/cgi/pmidlookup?view=long&pmid=18628391. 
  13. ^ a b c Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, Skelin M, Jevsek M, Fink H, Rupnik M, Walther DJ. (2009). Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 7(10):e1000229. PMID 19859528
  14. ^ Davidson S, Prokonov D, Taler M, et al. (February 2009). "Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes". Pediatr. Res. 65 (2): 236–41. doi:10.1203/PDR.0b013e318193594a. PMID 19262294. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0031-3998&volume=65&issue=2&spage=236. 
  15. ^ Mickael Lesurtel, Rolf Graf, Boris Aleil, Diego J. Walther, Yinghua Tian, Wolfram Jochum, Christian Gachet, Michael Bader, Pierre-Alain Clavien: "Platelet-Derived Serotonin Mediates Liver Regeneration"Science 7 April 2006: Vol. 312. no. 5770, pp. 104 - 107 http://www.sciencemag.org/cgi/content/abstract/312/5770/104
  16. ^ Ramadhan B. Matondo, Carine Punt, Judith Homberg, Mathilda J. M. Toussaint, Ronald Kisjes, Suzanne J. A. Korporaal, Jan Willem N. Akkerman, Edwin Cuppen, Alain de Bruin: "Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration", Am J Physiol Gastrointest Liver Physiol 296: G963-G968, 2009. http://ajpgi.physiology.org/cgi/content/abstract/296/4/G963
  17. ^ Collet C, Schiltz C, Geoffroy V, Maroteaux L, Launay JM, de Vernejoul MC: "The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation," FASEB J. 2008 Feb;22(2):418-27 http://www.fasebj.org/cgi/content/full/22/2/418
  18. ^ It Takes Guts To Build Bone, Scientists Discover
  19. ^ Cell 135, 825–837, November 28, 2008
  20. ^ McDuffie, J. E. (March 2000). "-hydroxytryptamine stimulates phosphorylation of p44/p42 mitogen-activated protein kinase activation in bovine aortic endothelial cell cultures". J. Cardiovasc. Pharmacol. 35 (3): 398. doi:10.1097/00005344-200003000-00008. http://www.cardiovascularpharm.com/pt/re/jcardiopharm/abstract.00005344-200003000-00008.htm;jsessionid=LLhXJN6PTXBlSKWpG3mTNChLl7C4wQZFQF2yyFWnlQLcdph7zkQq!-1990489359!181195628!8091!-1. 
  21. ^ EA Kravitz: "Hormonal control of behavior: amines and the biasing of behavioral output in lobsters" Science 30 September 1988: Vol. 241. no. 4874, pp. 1775 - 1781 http://www.sciencemag.org/cgi/reprint/241/4874/1775.pdf
  22. ^ Yeh SR, Fricke RA, Edwards DH (January 1996). "The effect of social experience on serotonergic modulation of the escape circuit of crayfish". Science 271 (5247): 366–9. PMID 8553075. http://www.cns.nyu.edu/events/spf/SPF_papers/yehetal1996.pdf. 
  23. ^ Caspi N, Modai I, Barak P, Waisbourd A, Zbarsky H, Hirschmann S, Ritsner M. (2001 Mar). "Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study". Int Clin Psychopharmacol. 16(2) (2): 111–5. PMID 11236069. 
  24. ^ Basky, Greg (02 May 2000). "Suicide linked to serotonin gene". CMAJ 162 (9): 1343. http://www.cmaj.ca/cgi/content/full/162/9/1343-a. 
  25. ^ Lesch, K.; Bengel, D.; Heils, A.; Sabol, S. Z.; Greenberg, B. D.; Petri, S.; Clemens, R.; Müller, J. B.; Hamer, D. H.; Murphy, D. L. (1996). "Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region". Science 274 (5292): 1527–31. doi:10.1126/science.274.5292.1527. PMID 8929413. 
  26. ^ Caspi, A.; Sugden, K.; Moffitt, T. E.; Taylor, A.; Craig, I. W.; Harrington, W.; McClay, J.; Mill, J.; Martin, J.; Braithwaite, A.; Poulton, R. (2003). "Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene". Science 301 (5631): 386–89. doi:10.1126/science.1083968. PMID 12869766. 
  27. ^ Crockett, M. J.; Clark, L.; Tabibnia, G.; Lieberman, M. D.; Robbins, T. W. (June 2008). "Serotonin modulates behavioral reactions to unfairness". Science 320 (5884): 1739. doi:10.1126/science.1155577. PMID 18535210. 
  28. ^ Essentials of Human Anatomy & Physiology, Eighth Edition, p. 336
  29. ^ Dolasetron
  30. ^ a b Alenina N, Kikic D, Todiras M, Mosienko V, Qadri F, Plehm R, Boyé P, Vilianovitch L, Sohr R, Tenner K, Hörtnagl H, Bader M. (2009). "Growth retardation and altered autonomic control in mice lacking brain serotonin". Proc Natl Acad Sci USA 106 (25): 10332–10337. doi:10.1073/pnas.0810793106. PMID 19520831. 
  31. ^ Frazer, A.; and Hensler, J. G. (1999). "Understanding the neuroanatomical organization of serotonergic cells in the brain provides insight into the functions of this neurotransmitter". in Siegel, G. J.. Basic Neurochemistry. Agranoff, Bernard W.; Fisher, Stephen K.; Albers, R. Wayne; Uhler, Michael D. (Sixth ed.). Lippincott Williams and Wilkins. ISBN 0-397-51820-X. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&db=books&doptcmdl=GenBookHL&term=raphe+AND+serotonin+release+AND+bnchm%5Bbook%5D+AND+160428%5Buid%5D&rid=bnchm.section.946#949. "In 1964, Dahlstrom and Fuxe (discussed in [2]), using the Falck-Hillarp technique of histofluorescence, observed that the majority of serotonergic soma are found in cell body groups, which previously had been designated as the raphe nuclei." 
  32. ^ |The Raphe nuclei group of neurons are located along the brain stem from the labels 'Mid Brain' to 'Oblongata', centered on the pons. (See relevant image.)
  33. ^ Hannon, J. & Hoyer, D. (2008)-Molecular biology of 5-HT receptors. Behavioural Brain Research 195: 198-213.
  34. ^ Mingyan Zhou, Karen Engel,1 and Joanne Wang* (2007). "Evidence for Significant Contribution of a Newly Identified Monoamine Transporter (PMAT) to Serotonin Uptake in the Human Brain". in ?. Biochemical Pharmacology. ? (Vol 73 Issue 1 ed.). Elsevier Inc.. doi:10.1016/j.bcp.2006.09.008. ISBN ?. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1828907. 
  35. ^ Walther DJ, Peter JU, Winter S, Höltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M. (2003). Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell. 115(7):851-62. PMID 14697203
  36. ^ Watts SW, Priestley JR, Thompson JM. (2009). Serotonylation of vascular proteins important to contraction. PLoS One. 4(5):e5682.PMID 19479059
  37. ^ Walther et. al (January 2003). "Synthesis of serotonin by a second tryptophan hydroxylase isoform". Science 299 (5603): 76. doi:10.1126/science.1078197. PMID 12511643. 
  38. ^ Levinson, Douglas F. "The Genetics of Depression: A Review." Rev. of The Genetics of Depression.
  39. ^ Schröder P, Abele C, Gohr P, Stuhlfauth-Roisch U, Grosse W. (1999). "Latest on enzymology of serotonin biosynthesis in walnut seeds". Adv Exp Med Biol. 467: 637–644. PMID 10721112. 
  40. ^ Titeler M, Lyon RA, Glennon RA. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 1988;94:213–216.
  41. ^ Nichols DE. Role of serotonergic neurons and 5-HT receptors in the action of hallucinogens. In: Baumgarten HG, Gothert M, eds. Serotonergic neurons and 5-HT receptors in the CNS. Berlin: Springer-Verlag, 1997:563–585.
  42. ^ Johnson MP, Hoffman AH, Nichols DE. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]-serotonin and [3H]-dopamine release from superfused rat brain slices. Eur J Pharmacol 1986;132:269–276.
  43. ^ Cell. 2008 Nov 28;135(5):825-37.
  44. ^ Benmansour, Saloua et al., Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level. Journal of Neuroscience, 1999, 19(23):10494-10501. http://www.jneurosci.org/cgi/content/full/19/23/10494
  45. ^ Audero, Enrica; Coppi, Elisabetta; Mlinar, Boris; Rossetti, Tiziana; Caprioli, Antonio; Al Banchaabouchi, Mumna; Corradetti, Renato; Gross, Cornelius (2008). "Sporadic Autonomic Dysregulation and Death Associated with Excessive Serotonin Autoinhibition". Science 321 (5885): 130–133. doi:10.1126/science.1157871. PMID 18599790. 
  46. ^ Lesurtel, M. et al. (2006). "Platelet-derived serotonin mediates liver regeneration". Science 312 (5770): 104–7. doi:10.1126/science.1123842. PMID 16601191. 
  47. ^ Paterson, D. S.; Trachtenberg, F. L.; Thompson, E.G.; et al. (November 2006). "Multiple serotonergic brainstem abnormalities in sudden infant death syndrome". JAMA 296 (17): 2124–32. doi:10.1001/jama.296.17.2124 (inactive 2009-10-17). PMID 17077377. 
  48. ^ Sciencedaily Report Anger and Aggression in Women: Blame It On Genetics
  49. ^ Farde, Lars; and Borg, Jacqueline; Section of psychiatry at Karolinska Institutet in Stockholm, Sweden 2003, the study and a vulgarized article
  50. ^ Svenningsson, P. et al. (2006). "Alterations in 5-HT1B receptor function by p11 in depression-like states". Science 311 (5757): 77–80. doi:10.1126/science.1117571. PMID 16400147. 
  51. ^ Isbister, G. K.; Bowe, S. J.; Dawson, A.; Whyte, I. M. (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". J. Toxicol. Clin. Toxicol. 42 (3): 277–85. doi:10.1081/CLT-120037428. PMID 15362595. 
  52. ^ Dunkley, E. J.; Isbister, G. K.; Sibbritt, D.; Dawson, A. H.; Whyte, I. M. (September 2003). "The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity". QJM 96 (9): 635–42. doi:10.1093/qjmed/hcg109. PMID 12925718. http://qjmed.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=12925718. 
  53. ^ a b Baskin, Steven I. (1991). Principles of Cardiac Toxicology. CRC Press. ISBN 0849388090. http://books.google.com/books?id=AW7M6jBixj4C&pg=PA626&lpg=PA626&dq=ergotamine+endocardial+fibrosis&source=web&ots=BrjNzsIc-N&sig=X-WM0TaoW6I5nkx6xiTsxJYvLHo.. 
  54. ^ Jähnichen, S.; Horowski, R.; Pertz, H. "Pergolide and Cabergoline But not Lisuride Exhibit Agonist Efficacy at Serotonin 5-HT2B Receptors".PDF (515 KB) Presentation. Retrieved on 2007-03-30.
  55. ^ ADRAC (August 2004). "Cardiac valvulopathy with pergolide". Aust Adv Drug React Bull 23 (4). http://www.tga.gov.au/adr/aadrb/aadr0408.htm.  Free full text from the Australian Therapeutic Goods Administration
  56. ^ Schade, Rene; Andersohn, Frank; Suissa, Samy; Haverkamp, Wilhelm; Garbe, Edeltraut (2007-01-04). "Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation". New England Journal of Medicine 356 (1): 29–38. doi:10.1056/NEJMoa062222. PMID 17202453. http://content.nejm.org/cgi/content/full/356/1/29. 
  57. ^ Zanettini, Renzo; Antonini, Angelo; Gatto, Gemma; Gentile, Rosa; Tesei, Silvana; Pezzoli, Gianna (2007-01-04). "Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease". New England Journal of Medicine 356 (1): 39–46. doi:10.1056/NEJMoa054830. PMID 17202454. http://content.nejm.org/cgi/content/full/356/1/39. 
  58. ^ "Food and Drug Administration Public Health Advisory". 2007-03-29. http://www.fda.gov/cder/drug/advisory/pergolide.htm. Retrieved 2007-04-27. 
  59. ^ "MedWatch - 2007 Safety Information Alerts. Permax (pergolide) and generic equivalents". U.S. Food and Drug Administration. March 29, 2007. http://www.fda.gov/medwatch/safety/2007/safety07.htm#Pergolide. Retrieved 2007-03-30. 
  60. ^ Johnson, D. J.; Sanderson, H.; Brain, R. A.; Wilson, C. J.; Solomon, K. R. (2007). "Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae". Ecotoxicol. Environ. Saf. 67 (1): 128–39. doi:10.1016/j.ecoenv.2006.03.016. PMID 16753215. 
  61. ^ McGowan, K.; Kane, A.; Asarkof, N. et al. (1983). "Entamoeba histolytica causes intestinal secretion: role of serotonin". Science 221 (4612): 762–4. doi:10.1126/science.6308760. PMID 6308760. 
  62. ^ McGowan, K.; Guerina, V.; Wicks, J.; Donowitz, M. (1985). "Secretory hormones of Entamoeba histolytica". Ciba Found. Symp. 112: 139–54. PMID 2861068. 
  63. ^ Banu, Naheed et al. (2005). "Neurohumoral alterations and their role in amoebiasis" (PDF). Indian J. Clin Biochem 20 (2): 142–5. doi:10.1007/BF02867414. http://medind.nic.in/iaf/t05/i2/iaft05i2p142.pdf. 
  64. ^ Acharya, D. P.; Sen, M. R.; Sen, P. C. (1989). "Effect of exogenous 5-hydroxytryptamine on pathogenicity of Entamoeba histolytica in experimental animals". Indian J. Exp. Biol. 27 (8): 718–20. PMID 2561282. 
  65. ^ Feldman, J. M.; Lee, E. M. (October 1985). "Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid". Am. J. Clin. Nutr. 42 (4): 639–43. PMID 2413754. http://www.ajcn.org/cgi/pmidlookup?view=long&pmid=2413754. 
  66. ^ BBC NEWS | Science & Environment | Locust swarms 'high' on serotonin
  67. ^ Rapport, Maurice M.; Green, Arda A.; Page, Irvine H. (December 1948). "Serum vasoconstrictor (serotonin). IV. Isolation and characterization". J. Biol. Chem. 176 (3): 1243–51. PMID 18100415. 
  68. ^ Nutritional Pharmacology Of Sleep & Depression
  69. ^ Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression
  70. ^ Young, S. N. (November 2007). "How to increase serotonin in the human brain without drugs" (PDF). J. Psychiatry Neurosci. 32 (6): 394–9. PMID 18043762. PMC 2077351. http://www.cma.ca/multimedia/staticContent/HTML/N0/l2/jpn/vol-32/issue-6/pdf/pg394.pdf. Retrieved 2008-12-30. 
  71. ^ http://books.google.com/books?id=2PxhgaCThccC&pg=PA49&lpg=PA49&dq=insulin+resistance+and+serotonin&source=web&ots=udW-o42zjY&sig=rtcdA8TTAkuxSxwvrR4TxYcnF30&hl=en&sa=X&oi=book_result&resnum=3&ct=result#PPA64,M1
  72. ^ Rao ML, Müller-Oerlinghausen B, Mackert A, Strebel B, Stieglitz RD, Volz HP. (August 1992). "Blood serotonin, serum melatonin and light therapy in healthy subjects and in patients with nonseasonal depression". Acta Psychiatr Scand 86 (2): 127–132. doi:10.1111/j.1600-0447.1992.tb03240.x. PMID 1529735. 
  73. ^ Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. (December 2002). "Effect of sunlight and season on serotonin turnover in the brain.". Lancet 360 (9348): 1840–1842. doi:10.1016/S0140-6736(02)11737-5. PMID 12480364. 
  74. ^ Acupuncture Stimulates the Release of Serotonin, but Not Dopamine, in the Rat Nucleus Accumbens
  75. ^ Clements, Rex; Betty Darnell (1980). "Myo-inositol content of common foods: development of a high-myo-inositol diet" (PDF). American Journal of Clinical Nutrition 33 (9): 1954–1967. PMID 7416064. PMID 7416064. http://www.ajcn.org/cgi/reprint/33/9/1954.pdf. Retrieved 2009-05-18. 

External links


 
 

Did you mean: serotonin (in biology, chemistry), 5-hydroxytryptamine, Raven's Nest, Serotonin (Lyrics - Nine Horses), Serotonin (Lyrics - Mansun), Serotonin (Lyrics - Simple Kid)


 

Copyrights:

Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2009. Published by Houghton Mifflin Company. All rights reserved.  Read more
Sci-Tech Encyclopedia. McGraw-Hill Encyclopedia of Science and Technology. Copyright © 2005 by The McGraw-Hill Companies, Inc. All rights reserved.  Read more
World of the Body. The Oxford Companion to the Body. Copyright © 2001, 2003 by Oxford University Press. All rights reserved.  Read more
Food and Fitness. Food and Fitness: A Dictionary of Diet and Exercise. Copyright © 1997, 2003 by Oxford University Press. All rights reserved.  Read more
Columbia Encyclopedia. The Columbia Electronic Encyclopedia, Sixth Edition Copyright © 2003, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/ Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Serotonin" Read more